Dyesol gains support from CSIRO for solar cell development
After the market closed on Friday, Dyesol (ASX: DYE) announced that it had signed a letter of intent with the Commonwealth Scientific and Industrial Research Organisation (CSIRO) to collaborate in the field of Perovskite Solar Cells (PSC).
To provide some background, PSC technology is a photovoltaic (PV) technology based on applying low-cost materials in a series of ultra-thin layers encapsulated by protective sealants.
While the company’s technologies would appear to have strong end markets, DYE is in the relatively early stages of development and as such should be considered a speculative stock. Investors should not make assumptions regarding potential development outcomes, nor should they use historical trading patterns as a guide to future share price performance. Independent professional financial advice should be sought if considering an investment in this company.
DYE’s technology has lower embodied energy in manufacture, produces stable electrical current, and has a strong competitive advantage in low light conditions relative to incumbent PV technologies. This technology can be directly integrated into the building envelope to achieve highly competitive building integrated photovoltaics (BIPV).
With DYE being a global leader in the development and commercialisation of PSC technology and the CSIRO already substantially invested in the group’s activities as its fourth largest individual shareholder, the establishment of an agreement to work towards a framework of collaboration, cooperation and coordination should be viewed as a positive in terms of an endorsement of the technology, as well as providing the potential to improve and/or fast track this development.
The non-binding letter of intent allows for individual projects to be the subject of specific binding agreements and also establishes a framework for the parties to combine their technical and commercial expertise in seeking to access various government funding sources in the future.
In response to this development, DYE’s Managing Director, Richard Caldwell said, “We believe CSIRO, currently our fourth-largest individual shareholder, is ideally positioned to explore opportunities to improve and enhance technology as we plan and execute the launch of Perovskite Solar Cell PV products for commercialisation for years to come”.
In the last fortnight DYE’s share price has increased from 19 cents to a high of 23 cents, representing an increase of more than 20%. While there was a slight retracement to 21.5 cents towards the end of last week, given this news came after the market closed on Friday, the related upside could be evident today.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.